A shape- and chemistry-based docking method and its use in the design of HIV-1 protease inhibitors

No abstract is available for this paper.

• Publication year

  1994

• Venue

  J. Comput. Aided Mol. Des.

• Publication date

  1994-06-01

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1007/BF00126742PMID 7964924
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors.

  1994cited by this paper
• Nonpeptide HIV protease inhibitors designed to replace a bound water

  1993cited by this paper
• A symmetric inhibitor binds HIV-1 protease asymmetrically.

  1993cited by this paper
• Automated docking with grid‐based energy evaluation

  1992cited by this paper
• Conformational analysis of flexible ligands in macromolecular receptor sites

  1992cited by this paper
• Automated site-directed drug design using molecular lattices

  1992cited by this paper
• CLIX: A search algorithm for finding novel ligands capable of binding proteins of known three‐dimensional structure

  1992cited by this paper
• Structure-Based Strategies for Drug Design and Discovery

  1992cited by this paper
• Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.

  1992cited by this paper
• Molecular docking using shape descriptors

  1992cited by this paper
• The HIV-1 Protease as a Therapeutic Target for AIDS

  1992cited by this paper
• Automated site-directed drug design using molecular lattices.

  1992cited by this paper
• The computer program LUDI: A new method for the de novo design of enzyme inhibitors

  1992cited by this paper
• X-Ray Crystal Structure of the HIV Protease Complex with L-700,417, an Inhibitor with Pseudo C2 Symmetry

  1991cited by this paper
• Refinement of the influenza virus hemagglutinin by simulated annealing.

  1991cited by this paper
• Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor.

  1991cited by this paper
• Computer design of bioactive molecules: A method for receptor‐based de novo ligand design

  1991cited by this paper
• Functionality maps of binding sites: A multiple copy simultaneous search method

  1991cited by this paper
• X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor.

  1990cited by this paper
• Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease.

  1990cited by this paper
• Slow- and fast-binding inhibitors of thermolysin display different modes of binding: crystallographic analysis of extended phosphonamidate transition-state analogues.

  1989cited by this paper
• Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution.

  1989cited by this paper
• Crystallographic structural analysis of phosphoramidates as inhibitors and transition-state analogs of thermolysin.

  1989cited by this paper
• Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease.

  1989cited by this paper
• Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: a 500-MHz proton nuclear magnetic resonance study.

  1989cited by this paper
• Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure.

  1988cited by this paper
• Structures of two thermolysin-inhibitor complexes that differ by a single hydrogen bond.

  1987cited by this paper
• A computational procedure for determining energetically favorable binding sites on biologically important macromolecules.

  1985cited by this paper
• Binding of N-carboxymethyl dipeptide inhibitors to thermolysin determined by X-ray crystallography: a novel class of transition-state analogues for zinc peptidases.

  1984cited by this paper
• Solvent-accessible surfaces of proteins and nucleic acids.

  1983cited by this paper
• A geometric approach to macromolecule-ligand interactions.

  1982cited by this paper
• Binding of hydroxamic acid inhibitors to crystalline thermolysin suggests a pentacoordinate zinc intermediate in catalysis.

  1982cited by this paper
• AMBER: Assisted model building with energy refinement. A general program for modeling molecules and their interactions

  1981cited by this paper
• The Cambridge Crystallographic Data Centre: computer-based search, retrieval, analysis and display of information

  1979cited by this paper
• The Protein Data Bank: a computer-based archival file for macromolecular structures.

  1977cited by this paper
• Areas, volumes, packing and protein structure.

  1977cited by this paper

• Discovery of Cobimetinib as a novel A-FABP inhibitor using machine learning and molecular docking-based virtual screening

  2022cites this paper
• Accurate Prediction of Inhibitor Binding to HIV-1 Protease Using CANDOCK

  2022cites this paper
• Natural Phytocompounds from Common Indian Spices for Identification of Three Potential Inhibitors of Breast Cancer: A Molecular Modelling Approach

  2022cites this paper
• Electrostatic Potential Energy in Protein-Drug Complexes.

  2021cites this paper
• SAnDReS: A Computational Tool for Docking.

  2019cites this paper
• Docking Screens for Drug Discovery

  2019influential citation
• Van der Waals Potential in Protein Complexes.

  2019cites this paper
• Research Techniques Made Simple: Molecular Docking in Dermatology - A Foray into In Silico Drug Discovery.

  2019cites this paper
• Docking with AutoDock4.

  2019cites this paper
• - Protein–Ligand Docking: From Basic Principles to Advanced Applications

  2015cites this paper
• - Library Design, Chemical Space, and Drug Likeness

  2015cites this paper
• Solving motion planning problems

  2014cites this paper
• Virtual Screening of Specific Insulin-Like Growth Factor 1 Receptor (IGF1R) Inhibitors from the National Cancer Institute (NCI) Molecular Database

  2012influential citation
• Comparison of Three Preprocessing Filters Efficiency in Virtual Screening: Identification of New Putative LXRβ Regulators As a Test Case

  2010cites this paper
• Docking and Scoring in Drug Discovery

  2010cites this paper
• Fully Automated Molecular Mechanics Based Induced Fit Protein—Ligand Docking Method.

  2009cites this paper
• Ligand shape emerges in solvent dipole ordering region at ligand binding site of protein

  2009cites this paper
• Fully Automated Molecular Mechanics Based Induced Fit Protein-Ligand Docking Method

  2008cites this paper
• The Docking Problem

  2008cites this paper
• Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.

  2007cites this paper
• Structure based drug design for HIV protease: from molecular modeling to cheminformatics.

  2007cites this paper
• Virtual Ligand Screening for Structure-based Drug Design: Approaches and Progress

  2007cites this paper
• Three‐Dimensional Structure Database Searches

  2007cites this paper
• Peptide Mimetic Design with the Aid of Computational Chemistry

  2007cites this paper
• Recent Advances in Ligand Design Methods

  2007cites this paper
• Similarity Searching in Databases of Chemical Structures

  2007cites this paper
• Receptor-based computational screening of compound databases: the main docking-scoring engines.

  2006cites this paper
• AFMoC enhances predictivity of 3D QSAR: a case study with DOXP-reductoisomerase.

  2005cites this paper
• Validation of automated docking programs for docking and database screening against RNA drug targets.

  2004cites this paper
• Target-biased scoring approaches and expert systems in structure-based virtual screening.

  2004cites this paper
• Guided docking approaches to structure-based design and screening.

  2004cites this paper
• Ligand-protein docking: cancer research at the interface between biology and chemistry.

  2003cites this paper
• LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites.

  2003cites this paper
• Molecular Docking in Structure-Based Design

  2003cites this paper
• Solving motion planning problems by iterative relaxation of constraints

  2003cites this paper
• Three‐dimensional Structure Searching

  2002cites this paper
• DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases

  2001cites this paper
• 3-D pharmacophores in drug discovery.

  2001cites this paper
• Modifications of the scoring function in FlexX for virtual screening applications

  2000cites this paper
• Structure‐Based Library Design

  2000cites this paper
• Pharmacophore Pattern Application in Virtual Screening. Library Design and QSAR

  2000cites this paper
• High-throughput and virtual screening: core lead discovery technologies move towards integration.

  2000cites this paper
• High-throughput and Virtual Screening: Core Lead Discovery Technologies Move Towards Integration

  2000cites this paper
• Towards understanding the mechanisms of molecular recognition by computer simulations of ligand–protein interactions

  1999cites this paper
• New approach for representation of molecular surface

  1998cites this paper
• Predicting structural effects in HIV‐1 protease mutant complexes with flexible ligand docking and protein side‐chain optimization

  1998cites this paper
• Characterization of receptors with a new negative image: Use in molecular docking and lead optimization

  1998cites this paper
• New trends in computational structure prediction of ligand-protein complexes for receptor-based drug design

  1997cites this paper
• Structure-based discovery of ligands targeted to the RNA double helix.

  1997cites this paper
• Critical evaluation of search algorithms for automated molecular docking and database screening

  1997cites this paper
• Alkylation of a catalytic aspartate group of the SIV protease by an epoxide inhibitor.

  1997cites this paper
• Using Molecular Graphics to Analyze Protein Structures

  1997cites this paper
• Novel angiotensin II receptor antagonists. Design, synthesis, and in vitro evaluation of dibenzo[a,d]cycloheptene and dibenzo[b,f]oxepin derivatives. Searching for bioisosteres of biphenylyltetrazole using a three-dimensional search technique.

  1995cites this paper
• Docking small-molecule ligands into active sites.

  1995cites this paper